F Civantos
Overview
Explore the profile of F Civantos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
521
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bustillo A, Telischi F, Weed D, Civantos F, Angeli S, Serafini A, et al.
Laryngoscope
. 2004 Apr;
114(3):434-40.
PMID: 15091215
Objectives/hypothesis: Octreotide is a somatostatin analogue that, when coupled to a radioisotope, produces a scintigraphic image of neuroendocrine tumors (NET) expressing somatostatin type 2 receptors (SSR 2). Octreotide scintigraphy (OS)...
2.
Manoharan M, Bird V, Kim S, Civantos F, Soloway M
BJU Int
. 2003 Sep;
92(6):539-44.
PMID: 14511029
Objective: To determine the outcome and predictors of recurrence in patients with a pretreatment prostate biopsy Gleason score (GS) of >/= 8 and treated with radical prostatectomy (RP). Patients And...
3.
Said S, Civantos F, Whiteman M, Young J
Otolaryngol Head Neck Surg
. 2001 Jul;
125(1):107-8.
PMID: 11458227
No abstract available.
4.
Hautmann S, Lokeshwar V, Schroeder G, Civantos F, Duncan R, Gnann R, et al.
J Urol
. 2001 May;
165(6 Pt 1):2068-74.
PMID: 11371930
Purpose: We examined the expression of 2 bladder tumor markers, hyaluronic acid (HA) and hyaluronidase (HAase), in bladder tissues and correlated tissue staining with the inferences of the HA-HAase urine...
5.
Vaidya A, Hawke C, Tiguert R, Civantos F, Soloway M
Urology
. 2001 May;
57(5):949-54.
PMID: 11337301
Objectives: During radical prostatectomy, wide local excision of the lateral prostatic fascia and neurovascular bundle on the ipsilateral side of the tumor is advocated if nerve sparing is likely to...
6.
Hautmann S, Schroeder G, Civantos F, Duncan R, Gnann R, Friedrich M, et al.
Urologe A
. 2001 Apr;
40(2):121-6.
PMID: 11315586
The heterogeneity of bladder cancer concerning progress of recurrence is an essential characteristic of this disease. Hyaluronic acid (HA) and its degrading enzyme hyaluronidase (HAase) are intricately associated with bladder...
7.
Vaidya A, Soloway M, Hawke C, Tiguert R, Civantos F
J Urol
. 2000 Dec;
165(1):47-50; discussion 50.
PMID: 11125361
Purpose: We reviewed our radical cystectomy series to determine whether the majority of patients present with muscle invasive bladder cancer. Materials And Methods: The records of 184 radical cystectomies performed...
8.
Civantos F
Mol Urol
. 2000 Nov;
4(3):117-21; discussion 123.
PMID: 11062365
Pattern and cellular changes attributable to neoadjuvant hormonal therapy (NHT) might cause the unwary pathologist to overgrade or fail to recognize a treated prostatic cancer. Overdiagnosis and overgrading of surgical...
9.
Posey J, Neulander E, Soloway M, Civantos F
Urology
. 2000 Jun;
55(6):949.
PMID: 10840481
Primary signet ring cell carcinoma of the urinary bladder and colon are rare disease entities that are aggressive, difficult to manage, and portend a poor prognosis. We present a case...
10.
Rubinowicz D, Soloway M, Lief M, Civantos F
J Urol
. 2000 Feb;
163(3):915.
PMID: 10688014
No abstract available.